Bayesian Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,804
Closed -$323K 175
2025
Q4
$323K Sell
4,804
-29,678
-86% -$2M 0.74% 45
2025
Q3
$2.53M Buy
34,482
+6,400
+23% +$425K 0.52% 42
2025
Q2
$1.46M Buy
28,082
+11,682
+71% +$665K 0.23% 132
2025
Q1
$1.05M Buy
+16,400
New +$953K 0.17% 156
2024
Q3
Sell
-31,260
Closed -$1.64M 821
2024
Q2
$1.64M Buy
+31,260
New +$1.37M 0.19% 145
2024
Q1
Sell
-31,500
Closed -$1.16M 907
2023
Q4
$1.16M Buy
+31,500
New +$1.19M 0.12% 203
2023
Q3
Sell
-46,100
Closed -$1.66M 820
2023
Q2
$1.66M Buy
46,100
+8,600
+23% +$293K 0.18% 159
2023
Q1
$1.43M Buy
37,500
+29,900
+393% +$1.4M 0.18% 168
2022
Q4
$432K Sell
7,600
-8,500
-53% -$435K 0.06% 394
2022
Q3
$637K Sell
16,100
-3,800
-19% -$168K 0.13% 221
2022
Q2
$876K Buy
+19,900
New +$861K 0.16% 186
2021
Q3
Sell
-7,800
Closed -$354K 450
2021
Q2
$354K Sell
7,800
-665
-8% -$29.4K 0.09% 239
2021
Q1
$353K Buy
+8,465
New +$386K 0.08% 317
2018
Q1
Sell
-22,800
Closed -$462K 687
2017
Q4
$462K Buy
+22,800
New +$419K 0.09% 337
2016
Q3
Sell
-11,200
Closed -$97K 412
2016
Q2
$97K Buy
+11,200
New +$111K 0.06% 365

Other funds holding HALO

Bayesian Capital Management's HALO Position: Q1 2026 in Review

Bayesian Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 4,804 shares — an estimated $323K sold.

Bayesian Capital Management first reported a position in HALO in Q2 2016 and held it in 15 quarters. The position peaked at $2.53M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Bayesian Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 4,804 Halozyme shares in Q1 2026, an estimated $323K.
  • Bayesian Capital Management first reported a position in Halozyme in Q2 2016 and held it in 15 quarters.
  • Bayesian Capital Management's Halozyme position peaked at $2.53M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.